All News

In the December 14, 2009, issue of The New Yorker magazine, Atul Gawande observed, “Cost is the specter haunting health care reform.” The idea (or better, mantra?) of cost as central to health care’s reform is not new but is surely a topic that demands this generation’s consideration. Most of the economic debate has been general, looking at national “bottom lines” rather than focusing on the “dollars and cents” of individual diseases. Let’s take a sobering look at rising costs in the context of specific diseases, beginning with psoriasis.

CMS' 2010 Fee Schedule ExplainedHear the latest on what CMS’ 2010 final physician fee schedule means for your practice with consultant Betsy Nicoletti.A Lawmaker and a PhysicianCongressman Michael Burgess, a Republican from Texas who was an OB/GYN before being elected to Congress, discusses healthcare reform and his unique perspective as a lawmaker and a physician.Podcast Series: How Healthcare Reform Affects Your Practice In this two-part podcast series, Robert Bennett, a member of MGMA’s government affairs staff, explains what parts of the healthcare reform law are likely to affect medical practices, and Dave Gans, vice president of practice management resources at MGMA, details what practices can do now to get ready for reform. 

Trends in HIV Care, Part 2: Antiretrovirals in the Pipeline, HIV/Hepatitis C Virus Coinfection, and Pharmacokinetics of Treatment Adherence-A Roundtable Discussion